PTIE Surges After-hours, Valeant Gets FDA Date, JAZZ Hits Right Notes

Shares of Pain Therapeutics Inc. (PTIE) soared more than 60% in extended trading on Monday, following positive regulatory guidance from a recent meeting with the FDA regarding REMOXY ER, its lead drug candidate.

from RTT - Biotech http://ift.tt/2nuTc18
via IFTTT